MedPath

A Study to Evaluate Endoscope-assisted, Minimally-invasive Cortical Access System for Chronic Subdural Evacuation

Not Applicable
Terminated
Conditions
Chronic Subdural Hematoma
Interventions
Device: Minimally Invasive Cortical Access System (MICAS)
Registration Number
NCT04502745
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this study is to evaluate a less-invasive alternative to the currently available method of removing aging blood in the subdural space.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
6
Inclusion Criteria
  • Must be 55 years of age or greater.
  • Have a clinically symptomatic chronic subdural hematoma greater than 1 cm in maximal thickness and be judged clinically to need subdural evacuation.
Read More
Exclusion Criteria
  • Failure to obtain consent.
  • Vulnerable study population.
  • Any need for chronic anticoagulation.
  • Pregnancy (verified by pregnancy testing at screening or medical history of a hysterectomy, oophorectomy, or post-menopausal).Prior surgery for subdural hematoma.
  • Glasgow Coma Scale (GCS) less than 8.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Treatment GroupMinimally Invasive Cortical Access System (MICAS)During clinically indicated surgery for subdural hematoma, the patient will undergo a single burr hole evacuation with the MICAS device with endoscopic assistance.
Primary Outcome Measures
NameTimeMethod
Incidence of all serious adverse events3 years

Number of adverse events including unanticipated adverse device effects

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath